Viewing StudyNCT02393794



Ignite Creation Date: 2024-05-06 @ 3:52 AM
Last Modification Date: 2024-10-26 @ 11:40 AM
Study NCT ID: NCT02393794
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-04-27
First Post: 2015-03-13

Brief Title: Cisplatin Plus Romidepsin Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer TNBC
Sponsor: Priyanka Sharma
Organization: University of Kansas Medical Center

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Triple-Negative Breast Cancer
Keywords:
Name View
TNBC View
BRCA1 View
BRCA2 View